Combined pembrolizumab and bevacizumab therapy in heavily treated recurrent ovarian cancer.

Saved in:

Bibliographic Details
Title:	Combined pembrolizumab and bevacizumab therapy in heavily treated recurrent ovarian cancer.
Authors:	Shin-Yi Wang¹, Yu-Ting Chou¹, Kuo-Chang Wen^1,2, Phui-Ly Liew^3,4, Yueh-Hsun Lu^5,6,7, Lin-Yu Chen¹, Pi-Lin Sung^1,2, Hung-Cheng Lai^1,2,8, Ling-Hui Chu^1,2 18418@s.tmu.edu.tw
Source:	European Journal of Gynaecological Oncology. Aug2025, Vol. 46 Issue 8, p48-57. 10p.
Database:	Academic Search Ultimate

Description
ISSN:	03922936
DOI:	10.22514/ejgo.2025.108